@article{article, title  = {{Dupilumab safety and efficacy up to 1 Year in children aged 6 months to 5 years with atopic dermatitis: results from a phase 3 open-label extension study}},

 publisher = {{Springer Science and Business Media LLC}},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/213392 }},

 year = {{2024}},

 month = {{5}},

 author = {{Paller AS and Siegfried EC and Simpson EL and Cork MJ and Sidbury R and Chen IH and Khokhar FA and Xiao J and Dubost-Brama A and Bansal A}},

 doi = {{10.1007/s40257-024-00859-y}},

 volume = {{25}},

 journal = {{American Journal of Clinical Dermatology}},

 issue = {{4}},

 pages = {{655-668}},

 note = {{Accessed on 2025/04/05}}}